# Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

> **NCT06414096** · PHASE1 · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 5 (estimated)

## Conditions studied

- Infertility
- Obesity

## Interventions

- **DRUG:** Follicle Stimulating Hormone

## Key facts

- **NCT ID:** NCT06414096
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-11
- **Final completion:** 2026-11
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414096, "Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06414096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*